Neurogene
Price & Volume
Stats
See moreOpen | $21.38 |
Previous Close | $20.76 |
Day Range | $20.96-$21.61 |
52W Range | $10.46-$37.26 |
Market Cap | $300.2M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$74.8M |
Diluted EPS | -$4.24 |
News
See moreYahoo Finance • 2 months ago
Block upgraded, Duolingo downgraded: Wall Street's top analyst calls
Yahoo Finance • 2 months ago
Neurogene Gets FDA Breakthrough Tag For NGN-401 In Rett Syndrome; Stock Up
Yahoo Finance • 11 months ago
Short Report: Bears bite into Krispy Kreme after another weak earnings report
About
CEO | Dr. Rachel L. McMinn Ph.D. |
CFO | Ms. Christine Mikail Cvijic J.D. |
Address | 535 W 24th Street, New York, NY, United States, 10011 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 131 |
